共 35 条
- [21] Comparative effectiveness of second-line biological therapies for Ulcerative colitis and Crohn's disease in patients with prior failure of anti-tumour necrosis factor treatmentJOURNAL OF CROHNS & COLITIS, 2021, 15 : S531 - S531Hyun, H. K.Yu, J.Kang, E. A.Park, J.Park, S. J.Park, J. J.Kim, T. I.Kim, W. H.Cheon, J. H.
- [22] Comparative effectiveness of second-line biological therapies for ulcerative colitis and Crohn's disease in patients with prior failure of anti-tumour necrosis factor treatmentBMC GASTROENTEROLOGY, 2022, 22 (01)Hyun, Hye KyungZhang, Hyun-SooYu, JongwookKang, Eun AePark, JihyePark, Soo JungPark, Jae JunKim, Tae IlKim, Won HoCheon, Jae Hee
- [23] Recognition of bactericidal/permeability-increasing protein by perinuclear anti-neutrophil cytoplasmic antibody-positive sera from ulcerative colitis patients: Prevalence and clinical significanceSCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1998, 33 (12) : 1284 - 1288Vecchi, MSinico, ABianchi, MBRadice, AGionchetti, PCampieri, MDe Franchis, R
- [24] Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registryTHERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17Calafat, MargalidaTorres, PaolaTosca-Cuquerella, JoanSanchez-Aldehuelo, RubenRivero, MontserratIborra, MarisaGonzalez-Vivo, MariaVera, Isabelde Castro, LuisaBujanda, LuisBarreiro-de Acosta, ManuelGonzalez-Munoza, CarlosCalvet, XavierBenitez, Jose ManuelLlorente-Barrio, MonicaSuris, GerardCanete, FiorellaArias-Garcia, LaraMonfort, DavidCastano-Garcia, AndresGarcia-Alonso, Francisco JavierHuguet, Jose M.Marin-Jimenez, IgnacioLorente, RufoMartin-Cardona, AlbertFerrer, Juan AngelCamo, PatriciaGisbert, Javier P.Pajares, RamonGomollon, FernandoCastro-Poceiro, JesusMorales-Alvarado, JairLlao, JordinaRodriguez, AndresRodriguez, CristinaPerez-Galindo, PabloNavarro, MerceJimenez-Garcia, NuriaCarrillo-Palau, MartaBlazquez-Gomez, IsabelSese, EvaAlmela, PedroRamirez de la Piscina, PatriciaTaxonera, CarlosRodriguez-Lago, IagoCabrinety, LidiaVela, MilagrosMinguez, MiguelMesonero, FranciscoGarcia, Maria Jose
- [25] Treatment Failure and Clinical Response Differences in Fixed-Dosing versus Weight-Adjusted Anti-TNF Therapy in Obese Patients With Ulcerative ColitisAMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S635 - S636Schell, TrevorLee, AlexanderLindholm, Christopher R.Li, ZhanhaiSampene, EmmanuelSaha, Sumonha
- [26] Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/ 3 Study in Patients With Moderate to Severe DiseaseJOURNAL OF CROHNS & COLITIS, 2018, 12 (09): : 1021 - 1029Sandborn, William J.Bhandari, Bal R.Randall, CharlesYounes, Ziad H.Romanczyk, TomaszXin, YanWendt, EmilyChai, HaoMcKevitt, MattZhao, SallySundy, John S.Keshav, SatishDaneseh, Silvio
- [27] MDX-1100, a fully human anti-CXCL10 (IP-10) antibody, is a high affinity, neutralizing antibody that has entered Phase I clinical trials for the treatment of Ulcerative Colitis (UC).JOURNAL OF IMMUNOLOGY, 2007, 178Kuhne, MichellePreston, BenjaminWallace, StevenChen, SharlineVasudevan, GeethaWitte, AlisonCardarelli, Pina
- [28] Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patientsJournal of Gastroenterology, 2017, 52 : 788 - 799Marisa IborraJavier Pérez-GisbertMarta Maia Bosca-WattsAlicia López-GarcíaValle García-SánchezAntonio López-SanrománEsther HinojosaLucía MárquezSantiago García-LópezMaría ChaparroMontserrat AceitunoMargalida CalafatJordi GuardiolaBlanca BellocYolanda BerLuis BujandaBelén BeltránCristina Rodríguez-GutiérrezJesús BarrioJosé Luis CabriadaMontserrat RiveroRaquel CamargoManuel van DomselaarAlbert VilloriaHugo Salata SchutermanDavid HervásPilar Nos
- [29] Long-Term Mucosal Healing, Clinical Response and Clinical Remission in Patients With Ulcerative Colitis Treated With the Anti-MAdCAM-1 Antibody Ontamalimab: Results From the Open-Label Extension Study TURANDOT IIAMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S449 - S449Danese, SilvioSandborn, William J.Reinisch, WalterHebuterne, XavierKlopocka, MariaTarabar, DinoVanasek, TomasGregus, MilosHellstern, Paul A.Kim, Joo SungSparrow, MilesGorelick, Kenneth J.Goetsch, MartinaBliss, CalebGupta, CharuCataldi, FabioVermeire, Severine
- [30] Propensity score-matched real-world comparative treatment outcomes of Janus kinase inhibitors for ulcerative colitis in patients with and without prior exposure to anti-tumor necrosis factor α antibodyINTESTINAL RESEARCH, 2025,Ikenouchi, MaikoFukui, HirokazuYagi, SoichiNogami, AkiraKaku, KojiSato, ToshiyukiKawai, MikioKamikozuru, KojiYokoyama, YokoTakagawa, TetsuyaTomita, ToshihikoKobayashi, TakuShinzaki, Shinichiro